CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 231 filers reported holding CONMED CORP in Q1 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $19,394,210 | -14.2% | 279,778 | -0.9% | 0.01% | -27.3% |
Q1 2024 | $22,605,382 | -25.8% | 282,285 | +1.5% | 0.01% | -31.2% |
Q4 2023 | $30,458,452 | -0.4% | 278,134 | -8.3% | 0.02% | -5.9% |
Q3 2023 | $30,587,401 | -29.0% | 303,296 | -4.3% | 0.02% | -29.2% |
Q2 2023 | $43,081,886 | +30.4% | 317,035 | -0.1% | 0.02% | +20.0% |
Q1 2023 | $33,029,433 | +108424.5% | 317,401 | -7.6% | 0.02% | -4.8% |
Q4 2022 | $30,435 | -99.9% | 343,360 | +14.0% | 0.02% | +16.7% |
Q3 2022 | $24,142,000 | -15.1% | 301,133 | +1.4% | 0.02% | -10.0% |
Q2 2022 | $28,448,000 | -37.1% | 297,074 | -2.4% | 0.02% | -25.9% |
Q1 2022 | $45,237,000 | +2.6% | 304,525 | -2.1% | 0.03% | +8.0% |
Q4 2021 | $44,088,000 | +7.8% | 311,007 | -0.5% | 0.02% | 0.0% |
Q3 2021 | $40,891,000 | -7.5% | 312,547 | -2.9% | 0.02% | -10.7% |
Q2 2021 | $44,227,000 | +9.5% | 321,818 | +4.1% | 0.03% | 0.0% |
Q1 2021 | $40,385,000 | +13.3% | 309,249 | -2.8% | 0.03% | +3.7% |
Q4 2020 | $35,646,000 | +45.0% | 318,268 | +1.9% | 0.03% | +22.7% |
Q3 2020 | $24,582,000 | +6.7% | 312,476 | -2.4% | 0.02% | 0.0% |
Q2 2020 | $23,037,000 | +28.1% | 320,006 | +1.9% | 0.02% | 0.0% |
Q1 2020 | $17,980,000 | -45.4% | 313,952 | +6.6% | 0.02% | -33.3% |
Q4 2019 | $32,949,000 | -6.1% | 294,634 | -19.3% | 0.03% | -15.4% |
Q3 2019 | $35,089,000 | -19.3% | 364,944 | -28.1% | 0.04% | -18.8% |
Q2 2019 | $43,454,000 | -45.8% | 507,822 | -53.6% | 0.05% | -5.9% |
Q1 2019 | $80,117,000 | +115.4% | 1,095,380 | +89.1% | 0.05% | 0.0% |
Q4 2018 | $37,198,000 | -16.8% | 579,407 | +2.6% | 0.05% | -5.6% |
Q3 2018 | $44,728,000 | +4.1% | 564,601 | -3.8% | 0.05% | -3.6% |
Q2 2018 | $42,974,000 | +11.4% | 587,073 | -3.6% | 0.06% | +9.8% |
Q1 2018 | $38,585,000 | +22.9% | 609,267 | -1.1% | 0.05% | +24.4% |
Q4 2017 | $31,391,000 | -3.3% | 615,878 | -0.4% | 0.04% | -10.9% |
Q3 2017 | $32,446,000 | +6.3% | 618,378 | +3.2% | 0.05% | 0.0% |
Q2 2017 | $30,532,000 | +16.7% | 599,363 | +1.8% | 0.05% | +9.5% |
Q1 2017 | $26,160,000 | -6.3% | 589,051 | -6.9% | 0.04% | -14.3% |
Q4 2016 | $27,932,000 | +10.1% | 632,386 | -0.2% | 0.05% | +8.9% |
Q3 2016 | $25,372,000 | +16.5% | 633,349 | +43.5% | 0.04% | +12.5% |
Q2 2016 | $21,774,000 | +29.9% | 441,386 | +14.3% | 0.04% | +25.0% |
Q1 2016 | $16,767,000 | -1.6% | 386,330 | -0.1% | 0.03% | -3.0% |
Q4 2015 | $17,034,000 | -8.0% | 386,705 | -0.3% | 0.03% | -15.4% |
Q3 2015 | $18,520,000 | -18.8% | 387,933 | -0.9% | 0.04% | -11.4% |
Q2 2015 | $22,807,000 | +14.8% | 391,394 | -0.5% | 0.04% | +10.0% |
Q1 2015 | $19,862,000 | +8.9% | 393,394 | -3.0% | 0.04% | +5.3% |
Q4 2014 | $18,240,000 | +19.6% | 405,705 | -2.0% | 0.04% | +18.8% |
Q3 2014 | $15,245,000 | +413.1% | 413,810 | +514.9% | 0.03% | +433.3% |
Q2 2014 | $2,971,000 | +1.6% | 67,300 | 0.0% | 0.01% | -14.3% |
Q1 2014 | $2,924,000 | -7.3% | 67,300 | -9.3% | 0.01% | 0.0% |
Q4 2013 | $3,154,000 | +1.6% | 74,200 | -18.8% | 0.01% | -12.5% |
Q3 2013 | $3,104,000 | +8.7% | 91,400 | 0.0% | 0.01% | +14.3% |
Q2 2013 | $2,855,000 | – | 91,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |